Pharmaceutical nanotechnology experts are specialized scientists and researchers who focus on applying nanotechnology principles to the field of drug development and delivery. These experts leverage the unique properties of materials at the nanoscale—typically between 1 to 100 nanometers—to create innovative drug formulations that improve therapeutic efficacy, targeting, and patient compliance. Their work often involves designing nanoparticles, liposomes, nanoemulsions, and other nanocarriers that can enhance drug solubility, stability, and controlled release. By manipulating materials at such a minute scale, pharmaceutical nanotechnology experts enable drugs to cross biological barriers more effectively, reduce side effects by targeting specific tissues or cells, and develop novel treatment options for complex diseases such as cancer, neurological disorders, and infectious diseases.
The role of pharmaceutical nanotechnology experts extends beyond formulation development; they are also deeply involved in characterizing nanomaterials, assessing their safety and biocompatibility, and navigating regulatory pathways for novel nanomedicines. Their expertise requires interdisciplinary knowledge in pharmaceutics, materials science, molecular biology, and toxicology. As nanotechnology continues to revolutionize the pharmaceutical industry, these professionals play a crucial role in translating laboratory discoveries into clinically viable therapies. Their contributions not only pave the way for personalized medicine but also improve drug delivery efficiency, minimize toxicity, and ultimately enhance patient outcomes in modern healthcare.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India
Title : Bridging tradition and innovation: Inorganic meets green synthesis
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy